Information Provided By: 
Fly News Breaks for May 2, 2019
HUM
May 2, 2019 | 07:51 EDT
Oppenheimer analyst Michael Wiederhorn lowered his price target for Humana to $350 from $373, while reiterating an Outperform rating on the shares given the significant pullback in the stock. With the company's exposure to the attractive Medicare market and related utilization remaining moderate, the analyst believes Humana appears well-positioned for 2019 and beyond.
News For HUM From the Last 2 Days
